RESUMEN
BACKGROUND: Propofol is a widely used anesthetic and sedative, which has been reported to exert an anti-inflammatory effect. TLR4 plays a critical role in coordinating the immuno-inflammatory response during sepsis. Whether propofol can act as an immunomodulator through regulating TLR4 is still unclear. Given its potential as a sepsis therapy, we investigated the mechanisms underlying the immunomodulatory activity of propofol. METHODS: The effects of propofol on TLR4 and Rab5a (a master regulator involved in intracellular trafficking of immune factors) were investigated in macrophage (from Rab5a-/- and WT mice) following treatment with lipopolysaccharide (LPS) or cecal ligation and puncture (CLP) in vitro and in vivo, and peripheral blood monocyte from sepsis patients and healthy volunteers. RESULTS: We showed that propofol reduced membrane TLR4 expression on macrophages in vitro and in vivo. Rab5a participated in TLR4 intracellular trafficking and both Rab5a expression and the interaction between Rab5a and TLR4 were inhibited by propofol. We also showed Rab5a upregulation in peripheral blood monocytes of septic patients, accompanied by increased TLR4 expression on the cell surface. Propofol downregulated the expression of Rab5a and TLR4 in these cells. CONCLUSIONS: We demonstrated that Rab5a regulates intracellular trafficking of TLR4 and that propofol reduces membrane TLR4 expression on macrophages by targeting Rab5a. Our study not only reveals a novel mechanism for the immunomodulatory effect of propofol but also indicates that Rab5a may be a potential therapeutic target against sepsis.
Asunto(s)
Propofol , Sepsis , Ratones , Humanos , Animales , Propofol/farmacología , Propofol/uso terapéutico , Propofol/metabolismo , Receptor Toll-Like 4/metabolismo , Modelos Animales de Enfermedad , Macrófagos/metabolismo , Sepsis/complicaciones , Lipopolisacáridos/farmacología , Lipopolisacáridos/metabolismoRESUMEN
Abstract Purpose: To determine the effects of propofol and ketamine anesthesia on liver regeneration in rats after partial hepatectomy (PHT). Methods: Male Wistar albino rats were assigned randomly to four groups of 10. Anesthesia was induced and maintained with propofol in groups 1 and 2, and with ketamine in groups 3 and 4. PHT was undertaken in groups 1 and 3. Rats in groups 2 and 4 (control groups) underwent an identical surgical procedure, but without PHT. At postoperative day-5, rats were killed. Regenerated liver was removed, weighed, and evaluated (by immunohistochemical means) for expression of inducible nitric oxide synthase (iNOS), endothelial NOS (eNOS), apoptosis protease-activating factor (APAF)-1, and proliferating cell nuclear antigen (PCNA). Also, blood samples were collected for measurement of levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6. Results: Between groups 2 and 4, there were no differences in tissue levels of iNOS, eNOS, and APAF-1 or plasma levels of TNF-α and IL-6. eNOS expression was similar in group 1 and group 3. Expression of iNOS and APAF-1 was mild-to-moderate in group 1, but significantly higher in group 3. Groups 1 and 3 showed an increase in PCNA expression, but expression in both groups was comparable. Plasma levels of TNF-α and IL-6 increased to a lesser degree in group 1 than in group 3. Conclusion: Propofol, as an anesthetic agent, may attenuate cytokine-mediated upregulation of iNOS expression and apoptosis in an animal model of liver regeneration after partial hepatectomy.
Asunto(s)
Animales , Masculino , Propofol/farmacología , Apoptosis , Anestésicos Intravenosos/farmacología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Ketamina/farmacología , Regeneración Hepática/efectos de los fármacos , Distribución Aleatoria , Propofol/metabolismo , Regulación hacia Arriba , Interleucina-6/metabolismo , Interleucina-6/sangre , Ratas Wistar , Antígeno Nuclear de Célula en Proliferación/metabolismo , Anestésicos Intravenosos/metabolismo , Modelos Animales , Óxido Nítrico Sintasa de Tipo III/metabolismo , Factor Apoptótico 1 Activador de Proteasas/metabolismo , Hepatectomía , Ketamina/metabolismoRESUMEN
The aim of this study was to investigate the effect of propofol pretreatment on lipopolysaccharide (LPS)-induced acute lung injury (ALI) and the role of the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) pathway in this procedure. Survival was determined 48 h after LPS injection. At 1 h after LPS challenge, the lung wet- to dry-weight ratio was examined, and concentrations of protein, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in bronchoalveolar lavage fluid (BALF) were determined using the bicinchoninic acid method or ELISA. Lung injury was assayed via lung histological examination. PI3K and p-Akt expression levels in the lung tissue were determined by Western blotting. Propofol pretreatment prolonged survival, decreased the concentrations of protein, TNF-α, and IL-6 in BALF, attenuated ALI, and increased PI3K and p-Akt expression in the lung tissue of LPS-challenged rats, whereas treatment with wortmannin, a PI3K/Akt pathway specific inhibitor, blunted this effect. Our study indicates that propofol pretreatment attenuated LPS-induced ALI, partly by activation of the PI3K/Akt pathway.
Asunto(s)
Animales , Masculino , Lesión Pulmonar Aguda/tratamiento farmacológico , /metabolismo , Propofol/uso terapéutico , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/efectos de los fármacos , Lesión Pulmonar Aguda/inducido químicamente , Lesión Pulmonar Aguda/enzimología , Lesión Pulmonar Aguda/metabolismo , Western Blotting , Líquido del Lavado Bronquioalveolar/química , Ensayo de Inmunoadsorción Enzimática , Indicadores y Reactivos , /análisis , Estimación de Kaplan-Meier , Lipopolisacáridos , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Propofol/metabolismo , Quinolinas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Prpopofol (DIprivan) as induction and maintenance anaesthetic was in 35 patients A.S.A. I and II. Patients scheduled for different surgery. Pre inclution was with benzodiazepin 10 mg and atropi 0,001 followed 5 - 10 minutes later by 2-2,5 mg/kg op Propofol (Diprivan) under proxigenation. Aditonal fixed dosis of Propofol (Diprivan) were given apnea after induction was present in most of the patients, manual ventilation throgh a face mask. Cardiovascular parameters were more o less stable. A psychometric test consisting in identifying some words and to answer earmar king. No side efects were detected and anaesthesia was weel acepted by every patients entering this study with respect to efficacy and safety.
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anestésicos/uso terapéutico , Propofol/metabolismo , Propofol/farmacocinética , Anestésicos Intravenosos/farmacocinética , Apnea/fisiopatología , Bolivia , Cirugía General/tendencias , Drenaje , Frecuencia Cardíaca , Frecuencia Cardíaca/fisiología , Hipotensión/fisiopatología , Dolor/fisiopatología , Presión Sanguínea , RiesgoRESUMEN
El presente trabajo describe los efectos de la anestesia total intravenosa con propofol versus anestesia general con halotano, en cirugia otorrinolaringológica. Se formaron dos grupos de pacientes con el objeto de evaluar los niveles plasmáticos de glucosa con estas dos técnicas anestésicas. Se encontró un ligero incremento estadísticamente significativo, en los niveles de glucosa en el grupo de pacientes que recibió anestesia total intravenosa con propofol. Tal incremento no mostró repercución clínica. Se discute la importancia de estos hallazgos en la practica diaria de la anestesia